Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (Foscarnet)
- 28 February 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 94 (2) , 175-180
- https://doi.org/10.1016/0002-9343(93)90180-w
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDSAnnals of Internal Medicine, 1991
- A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Foscarnet Therapy for Acyclovir-ResistantMucocutaneous Herpes Simplex Virus Infection in 26 AIDS Patients: Preliminary DataThe Journal of Infectious Diseases, 1990
- Foscarnet Therapy of Cytomegalovirus Retinitis in AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1990
- Foscarnet in the Treatment of Cytomegalovirus Retinitis in Acquired Immune Deficiency SyndromeOphthalmology, 1989
- Foscarnet Therapy for Severe Acyclovir-Resistant Herpes Simplex Virus Type-2 Infections in Patients with the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1989
- Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeAntimicrobial Agents and Chemotherapy, 1989
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Antiviral effects of phosphonoformate (PFA, foscarnet sodium)Pharmacology & Therapeutics, 1982